back to overview

press

Interview with Christoph Kausch in biotechandmoney

May 02, 2018 + Jessica Di Palo
5 Min read

Dr Christoph Kausch, Managing Partner at MTIP, talks to Biotech and Money about the firm’s ambitions and its commitment to environmental, social, and governance values.

ESG compass forest

INVESTORVIEW: COMMITTING TO SOCIAL RESPONSIBILITY IN HEALTHCARE INVESTMENT

Swiss healthcare-focused venture capital firm MTIP is in the process of building a portfolio of digital health and medical technologies companies after closing its first CHF60 million fund in 2017. Dr. Christoph Kausch, Founding Partner and Chief Executive Officer at MTIP, talks to Biotech and Money about the firm’s ambitions and its commitment to environmental, social, and governance values.

Download the article here.

fun fact: bioandtechnology got rebranded to LSX Leaders. visit their website to learn more: www.lsxleaders.com

Share the Article

news

Digital healthcare: patient-first?

Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital

blog

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations

news

MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II

blog

How to pitch to a healthtech Investor

Blog Pitching

news

MTIP invests in Koa Health to make mental health treatment more accessible

New investment in Koa Health

news

MTIP scored fantastic grades in the UNPRI assessment report of 2020

UNPRI Report grades 2020

press

4 Health VCs Share Their Business Priorities and What is Next

Interview Techtour

news

MTIP invests in Trialbee

New investment in Trialbee

news

TytoCare closes $50 million round as the demand for telehealth accelerates

TytoCare closes new round

news

The digital healthtech sector is expanding – and so are we!

Two new empolyees start in April

news

MTIP has sucessfully exited Blueprint Genetics

Blueprint exit January 2020

news

New MTIP investment in Oviva

New investment in Oviva

press

Whitepaper: A positive prognosis for the future of healthtech

Our first Whitepaper

press

Elite Summit 2019 – Interview with our Managing Partner Christoph Kausch

Elite Summit 2019

news

MTIP Healthcare Clinic 2019

Healthcare clinic 2019

New MTIP investment in Cynerio

New investment in Cynerio

news

MTIP invests in Lumeon Ltd.

New investment in Lumeon

Magenverkleinerung mit der Handnähmaschine

Nitinotes news paper article

news

New MTIP investment in Quanta Dialysis Technologies

New investment in Quanta

news

MTIP’s Healthcare Clinic 2018

Healthcare Clinic 2018

press

Interview with Christoph Kausch in biotechandmoney

interview Bioandtechnology

news

New MTIP investment – Nitinotes Series A Round

New investment in Nitinotes

news

New investment in an Israeli based digital health company TytoCare

New investment in TytoCare

news

MTIP joins United Nations-supported Principles for Responsible Investments

MTIP signs Principles for Responsible Investments

news

MTIP invests in Blueprint Genetics

new investment in Blueprint Genetics